These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 17028247

  • 21. The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy.
    Yoneda K, Morii T, Nieda M, Tsukaguchi N, Amano I, Tanaka H, Yagi H, Narita N, Kimura H.
    Leuk Res; 2005 Feb; 29(2):147-52. PubMed ID: 15607362
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of clinical and immunological effects of intravenous and intradermal administration of α-galactosylceramide (KRN7000)-pulsed dendritic cells.
    Nicol AJ, Tazbirkova A, Nieda M.
    Clin Cancer Res; 2011 Aug 01; 17(15):5140-51. PubMed ID: 21653690
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.
    Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M.
    Cancer Res; 1999 Oct 15; 59(20):5102-5. PubMed ID: 10537282
    [Abstract] [Full Text] [Related]

  • 28. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.
    Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, Durrant S, Juji T.
    Exp Hematol; 2000 Mar 15; 28(3):276-82. PubMed ID: 10720692
    [Abstract] [Full Text] [Related]

  • 29. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 30. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008 Dec 01; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection.
    Inoue M, Kanto T, Miyatake H, Itose I, Miyazaki M, Yakushijin T, Sakakibara M, Kuzushita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Hepatol; 2006 Aug 01; 45(2):190-6. PubMed ID: 16580086
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy.
    Takahashi T, Haraguchi K, Chiba S, Yasukawa M, Shibata Y, Hirai H.
    Br J Haematol; 2003 Jul 01; 122(2):231-9. PubMed ID: 12846891
    [Abstract] [Full Text] [Related]

  • 38. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T, Fontaine J, Breuilh L, Paget C, Castro-Keller A, Vendeville C, Capron M, Leite-de-Moraes M, Trottein F, Faveeuw C.
    Infect Immun; 2007 May 01; 75(5):2171-80. PubMed ID: 17353286
    [Abstract] [Full Text] [Related]

  • 39. A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells.
    Nakajima J, Murakawa T, Fukami T, Goto S, Kaneko T, Yoshida Y, Takamoto S, Kakimi K.
    Eur J Cardiothorac Surg; 2010 May 01; 37(5):1191-7. PubMed ID: 20137969
    [Abstract] [Full Text] [Related]

  • 40. Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines.
    Lin H, Nieda M, Nicol AJ.
    Eur J Immunol; 2004 Oct 01; 34(10):2664-71. PubMed ID: 15368282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.